Article
Treatment of myelodysplasia with oral cyclosporin.
Clinical and laboratory haematology - 1 Aug 2002
Atoyebi W, Bywater L, Rawlings L, Brunskill S, Littlewood T J
Abstract excerpt
Recent studies have shown a good response to immunosuppressive treatment with cyclosporin A (CSA) in patients with the myelodysplastic syndrome (MDS). We have treated six transfusion-dependent MDS patients with CSA for a minimum of 3 months. None of these patients showed a significant response, while the drug was withdrawn in 3/6 patients because of intolerable side-effects. Two reasons for the failure of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
